Carboplatin May Be an Effective and Tolerable Treatment Option for Platinum-Sensitive Pancreatic Cancer Patients With Pre-existing Neuropathy
Cureus · 01.06.2026
DOI: 10.7759/cureus.110034 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 01.06.2026. Verfasst von Angela Yoo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, USA.
- Department of Pharmacy, Northwell Health Cancer Institute, New Hyde Park, USA.
- Department of Radiology, Northwell Health, New Hyde Park, USA.
- Department of Oncology, Northwell Health Cancer Institute, New Hyde Park, USA.
Zitieren
APA
Yoo, A., Galvet, J., Kim, S., Choy, A., & King, D. (2026). Carboplatin May Be an Effective and Tolerable Treatment Option for Platinum-Sensitive Pancreatic Cancer Patients With Pre-existing Neuropathy. Cureus. https://doi.org/10.7759/cureus.110034
Vancouver
Yoo A, Galvet J, Kim S, Choy A, King D. Carboplatin May Be an Effective and Tolerable Treatment Option for Platinum-Sensitive Pancreatic Cancer Patients With Pre-existing Neuropathy. Cureus. 2026. doi:10.7759/cureus.110034
BibTeX
@article{Yoo2026,
author = {Yoo, Angela and Galvet, Jennifer and Kim, Sara and Choy, Andy and King, Daniel},
title = {Carboplatin May Be an Effective and Tolerable Treatment Option for Platinum-Sensitive Pancreatic Cancer Patients With Pre-existing Neuropathy},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.110034}
}
EUVIMED